This earnings news release for Great-West Lifeco Inc. should be
read in conjunction with the Company's Management Discussion &
Analysis (MD&A) and Consolidated Annual Financial Statements
for the period ended December 31,
2022, prepared in accordance with International Financial
Reporting Standards (IFRS) as issued by the International
Accounting Standards Board unless otherwise noted. These reports
are available on greatwestlifeco.com under Financial Reports.
Additional information relating to Great-West Lifeco is available
on sedar.com. Readers are referred to the cautionary notes
regarding Forward-Looking Information and Non-GAAP Financial
Measures and Ratios at the end of this release. All figures are
expressed in millions of Canadian dollars, unless otherwise
noted.
WINNIPEG, MB, Feb. 8, 2023
/CNW/ - Great-West Lifeco Inc. (Lifeco or the Company) today
announced its fourth quarter 2022 results. Net earnings of
$1,026 million and base
earnings1 of $892
million were up from $765
million and $825 million in
the fourth quarter of 2021, respectively.
"Great-West Lifeco's fourth quarter performance was strong
against a backdrop of continuing macroeconomic instability. Each of
our businesses continued to deliver on their commitments to
stakeholders, while making progress against strategic priorities
including Empower's integration activities in the United States," said Paul Mahon, President and CEO of Great-West
Lifeco. "We are pleased with our top-line and bottom-line momentum
supported by effective risk management and disciplined capital
allocation across our diversified businesses. Given our strong
momentum and results, we have increased our common shareholder
dividend by 6%."
Key Financial Highlights
|
|
Base earnings
|
|
Net earnings
|
Common Shareholders
|
|
Q4 2022
|
|
Q4 2021
|
|
Q4 2022
|
|
Q4 2021
|
Segment earnings
|
|
|
|
|
|
|
|
|
Canada
|
$
|
295
|
$
|
317
|
$
|
380
|
$
|
307
|
United
States
|
|
185
|
|
156
|
|
162
|
|
92
|
Europe
|
|
239
|
|
213
|
|
287
|
|
239
|
Capital and Risk
Solutions
|
|
187
|
|
145
|
|
211
|
|
133
|
Lifeco
Corporate
|
|
(14)
|
|
(6)
|
|
(14)
|
|
(6)
|
Total earnings
|
$
|
892
|
$
|
825
|
$
|
1,026
|
$
|
765
|
EPS2
|
$
|
0.96
|
$
|
0.89
|
$
|
1.10
|
$
|
0.82
|
Return on equity2,3
|
|
13.6 %
|
|
14.6 %
|
|
13.6 %
|
|
14.0 %
|
Although the pace of interest rate increases slowed in the
fourth quarter, interest rates continued to increase generally in
response by central banks to elevated, broad based levels of
inflation which are impacting business and consumer confidence.
Equity markets remain volatile, ending higher than September 30, 2022 levels; however, relative to
the fourth quarter last year, average equity levels for the quarter
were down between 7% and 16% in Canada, the United
States (U.S.) and Europe
and level in the United Kingdom
(U.K.). In addition, the Canadian dollar weakened notably against
the British pound and the Euro, although strengthened against the
U.S. dollar compared to the fourth quarter of 2021.
Despite challenging market conditions, Lifeco's results reflect
the resilience of its diversified business portfolio and focus on
operational efficiency. Solid results in the Capital and Risk
Solutions and Europe segments
balanced softer results in Canada,
particularly in Individual Customer, and for the Company's wealth
management fee-based businesses in Canada and the U.S.
Base earnings per share (EPS) for the fourth quarter of 2022 of
$0.96 increased from
$0.89 a year ago. The increase
was primarily due to higher new business growth in the Capital and
Risk Solutions segment, base earnings of $64
million (US$47 million)
related to the acquisition of the retirement services business of
Prudential Financial, Inc. (Prudential) as well as favourable
experience in the Europe and
Capital and Risk Solutions segments. The increase was
partially offset by lower fee income in Canada and the U.S. as well as less favourable
experience in the Canada
segment.
Reported net EPS for the fourth quarter of 2022 was $1.10, up from $0.82 a year ago, primarily due to an increase in
base earnings as well as more favourable market-related impacts on
liabilities and actuarial assumption changes. In addition, the
Company had a net favourable impact of revaluation of net deferred
tax assets and actuarial liabilities resulting from an increase to
the Canadian federal corporation tax rate substantively enacted
during the fourth quarter of 2022. These items were partially
offset by higher restructuring and integration costs in the U.S.
segment.
Return on equity and base return on equity of 13.6% in the
fourth quarter of 2022 continued to be solid. Base return on equity
was modestly below the Company's target range, reflecting the
continued macroeconomic challenges experienced in the quarter.
______________________________
|
1 Base
earnings is a non-GAAP financial measure. Refer to the "Non-GAAP
Financial Measures and Ratios" section of this document for
additional details.
|
2 Base
EPS and base return on equity are non-GAAP ratios. Refer to the
"Non-GAAP Financial Measures and Ratios" section of this document
for additional details.
|
3 Base
return on equity and return on equity are calculated using the
trailing four quarters of applicable earnings and common
shareholders' equity.
|
Business Highlights
Performance against medium-term financial objectives in
2022
- Lifeco's annual base EPS4 of $3.455 declined 1.5% compared to 2021 (8.8%
compound annual growth rate5 over the last five years)
compared to 8%-10% per annum objective.
- Lifeco's base return on equity4 for 2022 was 13.6%
(13.1% average base return on equity over the last five years)
compared to 14%-15% objective.
- Lifeco's base dividend payout ratio4 in 2022 was
56.7% (58.3% average payout ratio over the last five years)
compared to 45%-55% objective.
Key strategic transactions advanced in-quarter
- The Company completed the integration of Massachusetts Mutual
Life Insurance Company's retirement business (MassMutual) as of
December 31, 2022 and has achieved
US$160 million of pre-tax run rate
cost synergies in line with original expectations. Empower is on
track to achieve run rate revenue synergies of US$30 million pre-tax in 2024 and revenue
synergies are expected to continue to grow beyond 2024. Empower
incurred restructuring and integration expenses of US$125 million pre-tax related to the MassMutual
acquisition, US$116 million of which
has been expensed, in line with original expectations.
- The Company completed the integration of Personal Capital
Corporation (Personal Capital) as of December 31, 2022. To date, the Company incurred
US$57 million of pre-tax
restructuring and integration costs, US$43
million of which has been expensed, in line with original
expectations.
- Integration activities with respect to Prudential continue and
the Company remains confident that customer retention and expense
synergies are on track. As of December 31,
2022, annualized run rate cost synergies of US$43 million pre-tax have been achieved. Revenue
synergies of US$20 million are
expected on a run-rate basis by the end of 2024 and are expected to
grow to US$50 million by 2026.
Capital strength and financial flexibility maintained
- The Company's capital position remained strong at December 31, 2022, with a LICAT
Ratio4,6 of 120% for Canada Life, Lifeco's major
Canadian operating subsidiary, increasing by two points in the
quarter due to the impact of earnings net of dividends and the
ongoing phasing in of the LICAT interest rate scenario shift in
North America as well as currency
movements. The increase was partially offset by increased capital
required to support business growth and the impact of interest rate
movements.
Consolidated assets of $701
billion and assets under administration (AUA)7 of
$2.5 trillion
- Consolidated assets were $701
billion and AUA were $2.5
trillion as at December 31,
2022, an increase of 11% and 9%, respectively, from
December 31, 2021.
_____________________________
|
4 This
metric is a non-GAAP ratio. Refer to the "Non-GAAP Financial
Measures and Ratios" section of this document for additional
details.
|
5 2017 base
earnings were calculated by excluding items from net earnings as
discussed in the "Non-GAAP Financial Measures and Ratios" section
of this document. In addition, the Company excluded earnings
related to the business transferred to Protective Life under an
indemnity reinsurance agreement in 2019 to provide a more accurate
comparison for the 5-year growth rate. 2017 base earnings were
$2,244 million and base earnings per share was $2.269 compared to
net earnings of $2,149 million and net earnings per share of
$2.173. Items excluded from 2017 base earnings included a positive
impact on actuarial assumption changes and management actions of
$243 million, a negative impact on market-related impacts on
liabilities of $3 million, restructuring and integration costs of
$160 million, a net charge on business disposition of $122 million,
a net charge on tax legislative impacts of $216 million and $163
million of earnings related to the business transferred to
Protective Life in 2019.
|
6 The Life
Insurance Capital Adequacy Test (LICAT) Ratio is based on the
consolidated results of The Canada Life Assurance Company (Canada
Life), Lifeco's major Canadian operating subsidiary. The LICAT
Ratio is calculated in accordance with the Office of Superintendent
of Financial Institutions (OSFI)' guideline - Life Insurance
Capital Adequacy Test. Refer to the "Capital Management and
Adequacy" section of the Company's 2022 annual MD&A for
additional details.
|
7 Assets
under administration is a non-GAAP financial measure. Refer to the
"Non-GAAP Financial Measures and Ratios" section of this document
for additional details.
|
Disciplined Choices that Enable Growth
Lifeco continues to focus on its core strategies of delivering
financial security and wellness solutions through the workplace,
providing advice-centered wealth management, delivering strong
investment and asset management and leveraging risk and capital
management expertise.
CANADA
- Canada Life is gearing up to support the wellbeing of an
additional 1.5 million Canadians covered by the Public Service
Health Care Plan (PSHCP). The Company is building additional
digital capabilities that will be leveraged by the rest of the
Group Customer business to improve efficiency and customer service.
For example, the Company has enriched plan member sites to allow
earlier access; members can register and access their plan and
coverage information even before they are fully eligible for their
employment benefits.
- Plan Member as Customers was rebranded as Freedom Experience.
The Company is leveraging this brand by renaming several
direct-to-consumer products distributed by Group Customer with the
Freedom Experience brand. A dedicated team will be focused on
distributing these products and bringing the Freedom Experience to
Canadians.
- Canada Life continues to modernize legacy technology platforms
and expand its SimpleProtect digital app features and coverage to
improve the advisor and customer experience. This follows the
acquisitions of majority interest in two distribution firms earlier
in 2022 to continue strengthening the Company's distribution
network.
- During the fourth quarter of 2022, Canada Life accessed
capabilities in Bangalore, India,
for the processing of client claims. The expansion leverages
existing Empower operations to drive efficiency and supports the
Canadian benefits payment back office and resource complement,
allowing the Company to process claims for Canadians nearly 24
hours a day, five days a week, to keep pace with customer
expectations and deliver an improved experience.
UNITED STATES
In addition to the updates to the strategic transactions
mentioned above:
- At Empower, the integration efforts of MassMutual are
substantially complete with customer asset and revenue retention
rates of over 86%, ahead of original targets. The Company has
achieved US$160 million of final
pre-tax run rate cost synergies in line with original
expectations.
- Empower continues to build its retail business by leveraging
Personal Capital capabilities to deliver hybrid digital advice and
wealth
management solutions to drive increased retail penetration,
realizing impressive sales growth of 15% over the third quarter of
2022 despite market volatility.
- Putnam sustained strong
investment performance. As of December 31,
2022, approximately 73% and 78% of Putnam's fund assets performed at levels above
the Lipper median on a three-year and five-year basis,
respectively. In addition, 43% and 66% of Putnam's fund assets were in the Lipper top
quartile on a three-year and five-year basis, respectively.
Putnam has 40 funds currently
rated 4 or 5 stars by Morningstar Ratings.
- During 2022, Putnam made a
series of product-related announcements to meet evolving market
demand for sustainable investment options including five actively
managed, transparent exchange traded funds (ETFs) which were
launched in January 2023, the
repositioning of Putnam's
RetirementReady Funds target-date series as the Putnam Sustainable
Retirement Funds, and the launching of two new transparent
and actively managed equity ETFs, focused on business development
companies and companies operating at the intersection of technology
and biology.
EUROPE
In Europe, the Company advanced
its strategic transactions in Ireland, expanding its operational scale and
offerings to clients.
- In the second quarter of 2021, a 50:50 joint venture agreement
was reached by Allied Irish Banks plc (AIB) and Canada Life Irish
Holding Company Limited to form a new life assurance company. In
December 2022, the joint venture
agreement received authorization in principle from the Central Bank
of Ireland.
- In Q4 2022, Irish Life completed
the portfolio transfer of Ark Life Assurance Company dac (Ark
Life), which was integrated into Irish
Life's Retail division effective October 1, 2022. This follows the purchase of Ark
Life on November 1, 2021 by Irish
Life Group Limited. During the fourth quarter of 2022, Ark Life
Assurance Company dac changed its legal name to Irish Life Ark
Dublin dac.
CAPITAL AND RISK SOLUTIONS
- The Capital and Risk Solutions segment continued to grow by
providing tailored solutions to customers while increasing
diversification within the portfolio. During 2022, the Capital and
Risk Solutions segment expanded its international presence in
targeted new markets, including Asia, while continuing to focus on core
markets and product expansion in Europe and the U.S.
The Company intends to invest strategically, both organically
and through acquisitions, to drive growth and productivity, while
maintaining strong risk and expense discipline, to deliver
sustainable long-term value to its customers and shareholders.
SEGMENTED OPERATING RESULTS
For reporting purposes, Lifeco's consolidated operating results
are grouped into five reportable segments – Canada, United
States, Europe, Capital and
Risk Solutions and Lifeco Corporate – reflecting the management and
corporate structure of the Company. For more information, refer to
the Company's 2022 Annual Management's Discussion and Analysis
(MD&A).
CANADA
- Q4 Canada segment base
earnings of $295 million and net
earnings of $380 million – Base
earnings for the fourth quarter of 2022 were $295 million, down 7% compared to the fourth
quarter of 2021, primarily due to lower fee income driven by lower
assets, and less favourable individual insurance and investment
related experience. These items were partially offset by changes in
certain tax estimates and strong Group long-term disability results
driven by effective claims management and disciplined pricing
actions. Net earnings for the fourth quarter of 2022 were
$380 million, up from
$307 million in the fourth quarter of
2021, primarily due to an $84 million
favourable impact resulting from an increase to the Canadian
statutory income tax rate.
UNITED STATES
- Q4 United States (U.S.)
Financial Services base earnings of US$151
million ($206 million) and net
earnings of US$138 million
($187 million) – U.S. Financial
Services base earnings for the fourth quarter of 2022 were
US$151 million ($206 million), up US$41
million or 37% from the fourth quarter of 2021. The increase
was primarily due to base earnings of US$47
million related to the Prudential acquisition as well as
higher contributions from investment experience. These items were
partially offset by lower fee income driven by lower average equity
markets and transaction volumes, as well as higher expenses driven
by business growth.
- Empower growth in AUA and participant accounts – Empower
AUA increased to US$1.3 trillion at
December 31, 2022 from US$1.2 trillion at December 31, 2021. Empower participant accounts
have grown to 17.8 million at December 31,
2022, up from 13.0 million at December 31, 2021 and 17.5 million at
September 30, 2022. The increases in
AUA and participants compared to December
31, 2021 were primarily the result of the acquisition of
Prudential.
- Q4 Putnam net loss of
US$20 million ($27 million) – Putnam's net loss for the fourth quarter of
2022 was US$20 million ($27 million), compared to net earnings of
US$35 million ($43 million) in the fourth quarter of 2021,
primarily due to lower other assets under
administration8 based fee income and the unfavourable
impact of certain tax items. For Putnam, there were no differences between net
earnings (loss) and base earnings (loss).
EUROPE
- Q4 Europe segment base
earnings of $239 million and net
earnings of $287 million – Base
earnings for the fourth quarter of 2022 were $239 million, up 12% compared to the fourth
quarter of 2021. The increase was primarily due to favourable
investment experience in the U.K. and Ireland as well as favourable longevity
experience in the U.K. These items were partially offset by less
favourable morbidity experience in Ireland, the unfavourable impact of currency
movement, and the non-recurrence of changes to certain tax
estimates in the U.K. in the prior year. Net earnings for the
fourth quarter of 2022 were $287
million, up $48 million from
the fourth quarter of 2021, primarily due to lower transaction
costs, including contingent consideration provisions, related to
acquisitions in Ireland and a net
charge on business disposition in the prior year. These items were
partially offset by lower contributions from actuarial assumption
changes.
CAPITAL AND RISK SOLUTIONS
- Q4 Capital and Risk Solutions segment base earnings of
$187 million and net earnings of
$211 million – Base earnings for
the fourth quarter of 2022 were $187
million, compared to $145
million in the fourth quarter of 2021, primarily due to
strong new business growth, favourable longevity experience and
improved claims experience on the U.S. life business. The increase
was partially offset by the impact of currency movement. Net
earnings for the fourth quarter of 2022 increased $78 million from the prior year, primarily due to
higher contributions from insurance contract liability basis
changes and a decrease in actuarial liabilities on a legacy block
of business with investment performance guarantees.
The Company's well-diversified businesses, combined with
business strength, resilience and experience managing through
market volatility, puts the Company in a strong position in the
current environment to leverage opportunities for the future.
____________________________
|
8 Refer to
the "Glossary" section of the Company's 2022 Annual Management's
Discussion and Analysis for additional details on the composition
of this measure.
|
Update on Transition to IFRS 17 and IFRS 9
IFRS 17, Insurance Contracts (IFRS 17) has replaced IFRS
4, Insurance Contracts (IFRS 4) effective January 1, 2023. While the new standard will
change the recognition and measurement of insurance contracts and
the corresponding presentation and disclosures in the Company's
financial statements, it is not expected to have a material
financial impact or to change the Company's underlying business
strategy. IFRS 9, Financial Instruments (IFRS 9) has
replaced IAS 39, Financial Instruments: Recognition and
Measurement effective January 1,
2023 and is not expected to lead to a material change in the
level of invested assets. Upon adoption of IFRS 17 and IFRS 9, the
Company expects an increase in net earnings volatility.
The Company will report under the new standards for the first
time for the quarter ended March 31,
2023. The Company continues to evaluate the impact of the
adoption of these standards. The expected impacts of the adoption
of IFRS 17 include:
- Businesses representing approximately 65% of base
earnings9,10 are expected to experience limited or no
impact;
- The January 1, 2022 shareholders'
equity is expected to decrease by approximately 12% on the adoption
of IFRS 17 on January 1, 2023 in line
with original expectations, primarily due to the establishment of
the contractual service margin (CSM), partially offset by the
removal of provisions no longer required under IFRS 17;
- The CSM established for in-force contracts as at January 1, 2022 was $6.3
billion associated with the shareholders' account and
$2.3 billion associated with the
participating account. This does not include the CSM on in-force
segregated fund business which does not have a material impact on
capital or opening equity;
- Low-single digit percentage decrease in proforma base
earnings9,10 is expected as a result of transition
with no material change to base earnings trajectory; however,
increased volatility in net earnings is expected driven by the
de-linking of asset and liability measurement. Actual differences
between IFRS 4 and IFRS 17 results in any given period will vary
depending on the composition of earnings drivers;
- Medium-term financial objectives for base EPS
growth11 and base dividend payout11 ratio
remain unchanged;
- Medium-term financial objective for base ROE11 has
increased by 2% to 16-17% reflecting the change in shareholders'
equity; and
- Financial strength will be maintained and a positive impact of
approximately 10 points to the March 31,
2023 Canada Life consolidated LICAT Ratio is
expected12 based on the 2023 LICAT Guideline and current
market and economic conditions.
________________________
|
9 This
is a non-GAAP financial measure. Refer to the "Non-GAAP Financial
Measures and Ratios" section of this document for additional
details.
|
10 Proforma
base and net earnings are calculated based on the expected 2023
earnings mix and composition as at the start of 2023, including the
reflection of insurance contract earnings on an IFRS 17 basis and
adjusted to reflect fully synergized earnings from the acquisitions
of MassMutual's and Prudential's retirement services businesses.
Many of these estimates and assumptions are based on factors and
events that are not within the control of the Company's management
and there is no assurance that they will prove to be correct. Refer
to "Cautionary Note regarding Forward-looking Information" and
"Cautionary Note regarding Non-GAAP Financial Measures" at the end
of this document.
|
11 This
metric is a non-GAAP ratio. Refer to the "Non-GAAP Financial
Measures and Ratios" section of this document for additional
details.
|
12 Actual
impact will depend on market and economic conditions and the
Company's operating results at the time of transition.
|
QUARTERLY DIVIDENDS
The Board of Directors approved a quarterly dividend of
$0.5200 per share on the common
shares of Lifeco, an increase of 6% payable March 31, 2023 to shareholders of record at the
close of business March 3, 2023.
In addition, the Directors approved quarterly dividends on
Lifeco's first preferred shares payable March 31, 2023 to shareholders of record at the
close of business March 3, 2023, as
follows:
First Preferred Shares
|
Amount, per share
|
Series G
|
$0.3250
|
Series H
|
$0.30313
|
Series I
|
$0.28125
|
Series L
|
$0.353125
|
Series M
|
$0.3625
|
Series N
|
$0.109313
|
Series P
|
$0.3375
|
Series Q
|
$0.321875
|
Series R
|
$0.3000
|
Series S
|
$0.328125
|
Series T
|
$0.321875
|
Series Y
|
$0.28125
|
For purposes of the Income Tax Act (Canada), and any similar provincial
legislation, the dividends referred to above are eligible
dividends.
Fourth Quarter Conference Call
Lifeco's fourth quarter conference call and audio webcast will
be held February 9, 2023 at
3:30 p.m. (ET). The call and webcast
can be accessed through greatwestlifeco.com/news-events/events or
by phone at:
- Participants in the Toronto
area: 416-915-3239
- Participants from North
America: 1-800-319-4610
A replay of the call will be available until March 10, 2023 and can be accessed by calling
1-855-669-9658 or 604-674-8052 (passcode: 9514). The archived
webcast will be available on greatwestlifeco.com.
Selected financial information is attached.
GREAT-WEST LIFECO INC.
Great-West Lifeco is an international financial services holding
company with interests in life insurance, health insurance,
retirement and investment services, asset management and
reinsurance businesses. We operate in Canada, the United
States and Europe under the
brands Canada Life, Empower, Putnam Investments, and Irish Life. At the end of 2022, our companies
had approximately 31,000 employees, 234,500 advisor relationships,
and thousands of distribution partners – all serving over 38
million customer relationships across these regions. Great-West
Lifeco trades on the Toronto Stock Exchange (TSX) under the ticker
symbol GWO and is a member of the Power Corporation group of
companies. To learn more, visit greatwestlifeco.com.
Basis of presentation
The annual consolidated financial statements of Lifeco have been
prepared in accordance with International Financial Reporting
Standards (IFRS) unless otherwise noted and are the basis for the
figures presented in this release, unless otherwise noted.
Cautionary note regarding Forward-Looking Information
This release contains forward-looking information.
Forward-looking information includes statements that are predictive
in nature, depend upon or refer to future events or conditions, or
include words such as "will", "may", "expects", "anticipates",
"intends", "plans", "believes", "estimates", "objective", "target",
"potential" and other similar expressions or negative versions
thereof. Forward-looking information includes, without limitation,
statements about the Company's operations, business (including
business mix), financial condition, expected financial performance
(including revenues, earnings or growth rates and medium-term
financial objectives), ongoing business strategies or prospects,
climate-related targets, anticipated global economic conditions and
possible future actions by the Company, including statements made
with respect to the expected cost (including deferred
consideration), benefits, timing of integration activities and
timing and extent of revenue and expense synergies of acquisitions
and divestitures, including but not limited to the acquisitions of
the full-service retirement business of Prudential, Personal
Capital and the retirement services business of Massachusetts
Mutual Life Insurance Company (MassMutual), expected capital
management activities and use of capital, estimates of risk
sensitivities affecting capital adequacy ratios, expected dividend
levels, expected cost reductions and savings, expected expenditures
or investments (including but not limited to investment in
technology infrastructure and digital capabilities and solutions),
the timing and completion of the joint venture between Allied Irish
Banks plc (AIB) and Canada Life Irish Holding Company Limited, the
impact of regulatory developments on the Company's business
strategy and growth objectives, the expected impact of the ongoing
pandemic health event resulting from the coronavirus (COVID-19) and
related economic and market impacts on the Company's business
operations, financial results and financial condition.
Forward-looking information also includes, without limitation,
statements about the expected impact (or lack of impact) of IFRS
17, Insurance Contracts and IFRS 9, Financial
Instruments on the Company's business strategy, financial
strength, deployable capital, Life Insurance Capital Adequacy Test
(LICAT) ratio, base and net earnings, shareholders' equity, ratings
and leverage ratios.
Forward-looking statements are based on expectations, forecasts,
estimates, predictions, projections and conclusions about future
events that were current at the time of the statements and are
inherently subject to, among other things, risks, uncertainties and
assumptions about the Company, economic factors and the financial
services industry generally, including the insurance, mutual fund
and retirement solutions industries. They are not guarantees of
future performance, and the reader is cautioned that actual events
and results could differ materially from those expressed or implied
by forward-looking statements. Many of these assumptions are based
on factors and events that are not within the control of the
Company and there is no assurance that they will prove to be
correct. In particular, statements about the expected impact of
IFRS 17 on the Company (including statements about the impact on
base and net earnings and the Canada Life Assurance Company LICAT
Ratio) are based on the Company's expected 2023 earnings mix and
composition as at the start of 2023, including the reflection of
insurance contract earnings on an IFRS 17 basis and adjusted to
reflect fully synergized earnings from the acquisitions of
MassMutual and Prudential's retirement services businesses, and on
current market and economic conditions. Further, the LICAT
sensitivities presented in this MD&A have been prepared on the
basis of IFRS 4, Insurance Contracts and IAS 39,
Financial Instruments: Recognition and Measurement (IAS 39)
and may change on transition to IFRS 17 and IFRS 9. In all cases,
whether or not actual results differ from forward-looking
information may depend on numerous factors, developments and
assumptions, including, without limitation, the severity, magnitude
and impact of the COVID-19 pandemic (including the effects of the
COVID-19 pandemic and the effects of governments' and other
businesses' responses to the COVID-19 pandemic on the economy and
the Company's financial results, financial condition and
operations), the duration of COVID-19 impacts and the availability
and adoption of vaccines, the effectiveness of vaccines, the
emergence of COVID-19 variants, geopolitical tensions and related
economic impacts, assumptions around sales, fee rates, asset
breakdowns, lapses, plan contributions, redemptions and market
returns, the ability to integrate the acquisitions of Personal
Capital and the retirement services businesses of MassMutual and
Prudential, the ability to leverage Empower's, Personal Capital's
and MassMutual's and Prudential's retirement services businesses
and achieve anticipated synergies, customer behaviour (including
customer response to new products), the Company's reputation,
market prices for products provided, sales levels, premium income,
fee income, expense levels, mortality experience, morbidity
experience, policy and plan lapse rates, participant net
contribution, reinsurance arrangements, liquidity requirements,
capital requirements, credit ratings, taxes, inflation, interest
and foreign exchange rates, investment values, hedging activities,
global equity and capital markets (including continued access to
equity and debt markets), industry sector and individual debt
issuers' financial conditions (including developments and
volatility arising from the COVID-19 pandemic, particularly in
certain industries that may comprise part of the Company's
investment portfolio), business competition, impairments of
goodwill and other intangible assets, the Company's ability to
execute strategic plans and changes to strategic plans,
technological changes, breaches or failure of information systems
and security (including cyber attacks), payments required under
investment products, changes in local and international laws and
regulations, changes in accounting policies and the effect of
applying future accounting policy changes, changes in actuarial
standards, unexpected judicial or regulatory proceedings,
catastrophic events, continuity and availability of personnel and
third party service providers, the Company's ability to complete
strategic transactions and integrate acquisitions, unplanned
material changes to the Company's facilities, customer and employee
relations or credit arrangements, levels of administrative and
operational efficiencies, changes in trade organizations, and other
general economic, political and market factors in North America and internationally.
The reader is cautioned that the foregoing list of assumptions
and factors is not exhaustive, and there may be other factors
listed in other filings with securities regulators, including
factors set out in other filings with securities regulators,
including factors set out in the Company's 2022 Annual MD&A
under "Risk Management and Control Practices" and "Summary of
Critical Accounting Estimates" and in the Company's annual
information form dated February 8,
2023 under "Risk Factors", which, along with other filings,
is available for review at www.sedar.com. The reader is also
cautioned to consider these and other factors, uncertainties and
potential events carefully and not to place undue reliance on
forward-looking information.
Other than as specifically required by applicable law, the
Company does not intend to update any forward-looking information
whether as a result of new information, future events or
otherwise.
Cautionary note regarding Non-GAAP Financial Measures and
Ratios
This release contains some non-Generally Accepted Accounting
Principles (GAAP) financial measures and non-GAAP ratios as defined
in National Instrument 52-112 "Non-GAAP and Other Financial
Measures Disclosure". Terms by which non-GAAP financial measures
are identified include, but are not limited to, "base earnings
(loss)", "base earnings (loss) (US$)" and "assets under
administration". Terms by which non-GAAP ratios are identified
include, but are not limited to, "base earnings per common share
(EPS)", and "base return on equity (ROE)". Non-GAAP financial
measures and ratios are used to provide management and investors
with additional measures of performance to help assess results
where no comparable GAAP (IFRS) measure exists. However, non-GAAP
financial measures and ratios do not have standard meanings
prescribed by GAAP (IFRS) and are not directly comparable to
similar measures used by other companies. Refer to the "Non-GAAP
Financial Measures and Ratios" section in this release for the
appropriate reconciliations of these non-GAAP financial measures to
measures prescribed by GAAP as well as additional details on each
measure and ratio.
FINANCIAL HIGHLIGHTS (unaudited)
(in
Canadian $ millions, except per share amounts)
|
|
As at or for the
three months ended
|
|
For the twelve
months ended
|
|
|
Dec.
31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
Dec.
31
2022
|
|
Dec. 31
2021
|
|
Earnings
|
|
|
|
|
|
|
|
|
|
|
|
Base
earnings1
|
$
|
892
|
$
|
688
|
$
|
825
|
$
|
3,219
|
$
|
3,260
|
|
Net earnings - common
shareholders
|
|
1,026
|
|
688
|
|
765
|
|
3,219
|
|
3,128
|
|
Per common
share
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
Base
earnings2
|
|
0.957
|
|
0.738
|
|
0.887
|
|
3.455
|
|
3.507
|
|
Net
earnings
|
|
1.101
|
|
0.738
|
|
0.822
|
|
3.455
|
|
3.365
|
|
Diluted net
earnings
|
|
1.100
|
|
0.738
|
|
0.820
|
|
3.452
|
|
3.360
|
|
Dividends
paid
|
|
0.490
|
|
0.490
|
|
0.490
|
|
1.960
|
|
1.804
|
|
Book
value3
|
|
26.60
|
|
25.61
|
|
24.71
|
|
|
|
|
|
Base return on
equity2
|
|
13.6 %
|
|
13.5 %
|
|
14.6 %
|
|
|
|
|
|
Return on
equity3
|
|
13.6 %
|
|
12.7 %
|
|
14.0 %
|
|
|
|
|
|
Total net
premiums
|
$
|
8,544
|
$
|
13,921
|
$
|
12,989
|
$
|
52,821
|
$
|
52,813
|
|
Total premiums and
deposits1
|
|
44,165
|
|
44,265
|
|
47,654
|
|
174,179
|
|
168,803
|
|
Fee and other
income
|
|
1,979
|
|
1,897
|
|
1,885
|
|
7,598
|
|
7,294
|
|
Net policyholder
benefits, dividends and
experience refunds
|
|
16,193
|
|
14,162
|
|
12,241
|
|
58,132
|
|
47,252
|
|
Total assets per
financial statements
|
$
|
701,455
|
$
|
672,764
|
$
|
630,488
|
|
|
|
|
|
Total assets under
management1
|
|
1,033,189
|
|
991,905
|
|
1,007,643
|
|
|
|
|
|
Total assets under
administration1,4
|
|
2,497,712
|
|
2,384,273
|
|
2,291,592
|
|
|
|
|
|
Total
equity
|
$
|
32,318
|
$
|
31,361
|
$
|
30,483
|
|
|
|
|
|
The Canada Life
Assurance Company
consolidated LICAT
Ratio5
|
|
120 %
|
|
118 %
|
|
124 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
This metric is a
non-GAAP financial measure. Refer to the "Non-GAAP Financial
Measures and Ratios" section of this document for additional
details.
|
2
|
This metric is a
non-GAAP ratio. Refer to the "Non-GAAP Financial Measures and
Ratios" section of this document for additional details.
|
3
|
Refer to the "Glossary"
section of the Company's 2022 Annual Management's Discussion and
Analysis for additional details on the composition of this
measure.
|
4
|
2021 comparative
figures have been restated to include Financial Horizons Group and
Excel Private Wealth Inc. assets under administration in the Canada
segment.
|
5
|
The Life Insurance
Capital Adequacy Test (LICAT) Ratio is based on the consolidated
results of The Canada Life Assurance Company (Canada Life),
Lifeco's major Canadian operating subsidiary. The LICAT Ratio is
calculated in accordance with the Office of Superintendent of
Financial Institutions' guideline - Life Insurance Capital Adequacy
Test. Refer to the "Capital Management and Adequacy" section
of the Company's 2022 Annual Management's Discussion and
Analysis for additional details.
|
Base
earnings1 and Net earnings - common shareholders
(unaudited)
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
|
Dec.
31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec.
31
2022
|
|
Dec. 31
2021
|
|
Base earnings
(loss)1
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
$
|
295
|
$
|
283
|
$
|
317
|
|
$
|
1,146
|
$
|
1,220
|
|
United
States
|
|
185
|
|
204
|
|
156
|
|
|
652
|
|
671
|
|
Europe
|
|
239
|
|
200
|
|
213
|
|
|
892
|
|
830
|
|
Capital and Risk
Solutions
|
|
187
|
|
1
|
|
145
|
|
|
532
|
|
547
|
|
Lifeco
Corporate
|
|
(14)
|
|
—
|
|
(6)
|
|
|
(3)
|
|
(8)
|
|
Lifeco base
earnings1
|
$
|
892
|
$
|
688
|
$
|
825
|
|
$
|
3,219
|
$
|
3,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
base earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial assumption
changes and other
management actions2
|
$
|
49
|
$
|
68
|
$
|
23
|
|
$
|
129
|
$
|
134
|
|
Market-related impacts
on liabilities2
|
|
38
|
|
(45)
|
|
20
|
|
|
(33)
|
|
24
|
|
Transaction costs
related to acquisitions3
|
|
(5)
|
|
20
|
|
(74)
|
|
|
(49)
|
|
(189)
|
|
Restructuring and
integration costs
|
|
(32)
|
|
(43)
|
|
(15)
|
|
|
(131)
|
|
(66)
|
|
Tax legislative
changes impact
|
|
84
|
|
—
|
|
—
|
|
|
84
|
|
(21)
|
|
Net gain/charge on
business dispositions4
|
|
—
|
|
—
|
|
(14)
|
|
|
—
|
|
(14)
|
|
Items excluded from
Lifeco base earnings
|
$
|
134
|
$
|
—
|
$
|
(60)
|
|
$
|
—
|
$
|
(132)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss)
- common shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
$
|
380
|
$
|
160
|
$
|
307
|
|
$
|
1,116
|
$
|
1,187
|
|
United
States
|
|
162
|
|
164
|
|
92
|
|
|
460
|
|
499
|
|
Europe
|
|
287
|
|
249
|
|
239
|
|
|
984
|
|
976
|
|
Capital and Risk
Solutions
|
|
211
|
|
115
|
|
133
|
|
|
662
|
|
532
|
|
Lifeco
Corporate
|
|
(14)
|
|
—
|
|
(6)
|
|
|
(3)
|
|
(66)
|
|
Lifeco net earnings
- common shareholders
|
$
|
1,026
|
$
|
688
|
$
|
765
|
|
$
|
3,219
|
$
|
3,128
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
This metric is a
non-GAAP financial measure. Refer to the "Non-GAAP Financial
Measures and Ratios" section of this document for additional
details.
|
2
|
Refer to the "Glossary"
section of the Company's 2022 Annual Management's Discussion and
Analysis for additional details on the composition of this
measure.
|
3
|
The transaction costs
relate to acquisitions in the U.S. segment (the full-service
retirement business of Prudential, Personal Capital and the
retirement services business of MassMutual) as well as acquisitions
in the Europe segment. In addition, the twelve months ended
December 31, 2021 included a provision for payments relating to the
Company's acquisition of Canada Life.
|
4
|
For the three and
twelve months ended December 31, 2021, net gain/charge on business
dispositions includes a $14 million net charge on business
disposition in the Europe Corporate business unit.
|
NON-GAAP FINANCIAL MEASURES AND RATIOS
The Company uses several non-GAAP financial measures to measure
overall performance of the Company and to assess each of its
business units. A financial measure is considered a non-GAAP
measure for Canadian securities law purposes if it is presented
other than in accordance with generally accepted accounting
principles (GAAP) used for the Company's consolidated financial
statements. The consolidated financial statements of the Company
have been prepared in compliance with IFRS as issued by the IASB.
Non-GAAP financial measures do not have a standardized meaning
under GAAP and may not be comparable to similar financial measures
presented by other issuers. Investors may find these financial
measures useful in understanding how management views the
underlying business performance of the Company.
Base earnings (loss)
Base earnings (loss) reflect management's view of the underlying
business performance of the Company and provides an alternate
measure to understand the underlying business performance compared
to IFRS net earnings. Base earnings (loss) exclude the
following items:
- The impact of actuarial assumption changes and other management
actions;
- The net earnings impact related to the direct equity and
interest rate market impacts on insurance and investment contract
liabilities, net of hedging, and related deferred tax liabilities,
which includes:
-
- the impact of hedge ineffectiveness related to segregated fund
guarantee liabilities that are hedged and the performance of the
related hedge assets;
- the impact on segregated fund guarantee liabilities not
hedged;
- the impact on general fund equity and investment properties
supporting insurance contract liabilities;
- other market impacts on insurance and investment contract
liabilities and deferred tax liabilities, including those arising
from the difference between actual and expected market movements;
and
- Certain items that, when removed, assist in explaining the
Company's underlying business performance including restructuring
costs, integration costs related to business acquisitions, material
legal settlements, material impairment charges related to goodwill
and intangible assets, impact of substantially enacted income tax
rate changes and other tax impairments and net gains, losses or
costs related to the disposition or acquisition of a business.
Lifeco
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec. 31
2022
|
|
Dec. 31
2021
|
Base
earnings
|
$
|
892
|
$
|
688
|
$
|
825
|
|
$
|
3,219
|
$
|
3,260
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
Lifeco base earnings
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial assumption
changes and other
management actions (pre-tax)
|
$
|
49
|
$
|
24
|
$
|
28
|
|
$
|
88
|
$
|
148
|
Income tax (expense)
benefit
|
|
—
|
|
44
|
|
(5)
|
|
|
41
|
|
(14)
|
Market-related impact
on liabilities (pre-tax)
|
|
46
|
|
(54)
|
|
22
|
|
|
(41)
|
|
35
|
Income tax (expense)
benefit
|
|
(8)
|
|
9
|
|
(2)
|
|
|
8
|
|
(11)
|
Transaction costs
related to acquisitions
(pre-tax)
|
|
(5)
|
|
16
|
|
(76)
|
|
|
(68)
|
|
(207)
|
Income tax (expense)
benefit
|
|
—
|
|
4
|
|
2
|
|
|
19
|
|
18
|
Restructuring and
integration costs (pre-tax)
|
|
(43)
|
|
(58)
|
|
(21)
|
|
|
(178)
|
|
(90)
|
Income tax (expense)
benefit
|
|
11
|
|
15
|
|
6
|
|
|
47
|
|
24
|
Tax legislative
changes impact (pre-tax)
|
|
55
|
|
—
|
|
—
|
|
|
55
|
|
—
|
Income tax (expense)
benefit
|
|
29
|
|
—
|
|
—
|
|
|
29
|
|
(21)
|
Net gain/charge on
business dispositions (pre-
tax)
|
|
—
|
|
—
|
|
(14)
|
|
|
—
|
|
(14)
|
Total pre-tax items
excluded from base
earnings
|
$
|
102
|
$
|
(72)
|
$
|
(61)
|
|
$
|
(144)
|
$
|
(128)
|
Impact of items
excluded from base earnings
on income taxes
|
|
32
|
|
72
|
|
1
|
|
|
144
|
|
(4)
|
Net earnings -
common shareholders
|
$
|
1,026
|
$
|
688
|
$
|
765
|
|
$
|
3,219
|
$
|
3,128
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec. 31
2022
|
|
Dec. 31
2021
|
Base
earnings
|
$
|
295
|
$
|
283
|
$
|
317
|
|
$
|
1,146
|
$
|
1,220
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
base earnings
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial assumption
changes and other
management actions (pre-tax)
|
$
|
1
|
$
|
(164)
|
$
|
(18)
|
|
$
|
(161)
|
$
|
(58)
|
Income tax (expense)
benefit
|
|
1
|
|
44
|
|
5
|
|
|
44
|
|
15
|
Market-related impacts
on liabilities (pre-
tax)
|
|
(2)
|
|
(4)
|
|
4
|
|
|
4
|
|
13
|
Income tax (expense)
benefit
|
|
1
|
|
1
|
|
(1)
|
|
|
(1)
|
|
(3)
|
Tax legislative
changes impact (pre-tax)
|
|
55
|
|
—
|
|
—
|
|
|
55
|
|
—
|
Income tax (expense)
benefit
|
|
29
|
|
—
|
|
—
|
|
|
29
|
|
—
|
Net earnings -
common shareholders
|
$
|
380
|
$
|
160
|
$
|
307
|
|
$
|
1,116
|
$
|
1,187
|
|
|
|
|
|
|
|
|
|
|
|
|
United
States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec. 31
2022
|
|
Dec. 31
2021
|
Base
earnings
|
$
|
185
|
$
|
204
|
$
|
156
|
|
$
|
652
|
$
|
671
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
base earnings
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial assumption
changes and other
management actions (pre-tax)
|
$
|
—
|
$
|
—
|
$
|
2
|
|
$
|
—
|
$
|
7
|
Income tax (expense)
benefit
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
(1)
|
Market-related impact
on liabilities (pre-tax)
|
|
12
|
|
(28)
|
|
(1)
|
|
|
(40)
|
|
(5)
|
Income tax (expense)
benefit
|
|
(3)
|
|
6
|
|
—
|
|
|
8
|
|
—
|
Restructuring and
integration costs (pre-tax)
|
|
(43)
|
|
(58)
|
|
(21)
|
|
|
(178)
|
|
(90)
|
Income tax (expense)
benefit
|
|
11
|
|
15
|
|
6
|
|
|
47
|
|
24
|
Transaction costs
related to acquisitions
(pre-tax)
|
|
—
|
|
21
|
|
(52)
|
|
|
(48)
|
|
(115)
|
Income tax (expense)
benefit
|
|
—
|
|
4
|
|
2
|
|
|
19
|
|
8
|
Net earnings -
common shareholders
|
$
|
162
|
$
|
164
|
$
|
92
|
|
$
|
460
|
$
|
499
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec. 31
2022
|
|
Dec. 31
2021
|
Base
earnings
|
$
|
239
|
$
|
200
|
$
|
213
|
|
$
|
892
|
$
|
830
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
base earnings
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial assumption
changes and other
management actions (pre-tax)
|
$
|
38
|
$
|
77
|
$
|
59
|
|
$
|
128
|
$
|
219
|
Income tax (expense)
benefit
|
|
(1)
|
|
(8)
|
|
(13)
|
|
|
(11)
|
|
(33)
|
Market-related impact
on liabilities (pre-tax)
|
|
21
|
|
(17)
|
|
19
|
|
|
(7)
|
|
27
|
Income tax (expense)
benefit
|
|
(5)
|
|
2
|
|
(1)
|
|
|
2
|
|
(8)
|
Transaction costs
related to acquisitions
(pre-tax)
|
|
(5)
|
|
(5)
|
|
(24)
|
|
|
(20)
|
|
(24)
|
Income tax (expense)
benefit
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
Tax legislative
changes impact on liabilities
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
(21)
|
Net gain/charge on
business dispositions
(pre-tax)
|
|
—
|
|
—
|
|
(14)
|
|
|
—
|
|
(14)
|
Net earnings -
common shareholders
|
$
|
287
|
$
|
249
|
$
|
239
|
|
$
|
984
|
$
|
976
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital and Risk
Solutions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec. 31
2022
|
|
Dec. 31
2021
|
Base
earnings
|
$
|
187
|
$
|
1
|
$
|
145
|
|
$
|
532
|
$
|
547
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
base earnings
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial assumption
changes and other
management actions (pre-tax)
|
$
|
10
|
$
|
111
|
$
|
(15)
|
|
$
|
121
|
$
|
(20)
|
Income tax (expense)
benefit
|
|
—
|
|
8
|
|
3
|
|
|
8
|
|
5
|
Market-related impact
on liabilities
|
|
15
|
|
(5)
|
|
—
|
|
|
2
|
|
—
|
Income tax expense
(benefit)
|
|
(1)
|
|
—
|
|
—
|
|
|
(1)
|
|
—
|
Net earnings -
common shareholder
|
$
|
211
|
$
|
115
|
$
|
133
|
|
$
|
662
|
$
|
532
|
Lifeco
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec. 31
2022
|
|
Dec. 31
2021
|
Base earnings
(loss)
|
$
|
(14)
|
$
|
—
|
$
|
(6)
|
|
$
|
(3)
|
$
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
Items excluded from
base earnings (loss)
|
|
|
|
|
|
|
|
|
|
|
|
Transaction costs
related to acquisitions
(pre-tax)
|
$
|
—
|
$
|
—
|
$
|
—
|
|
$
|
—
|
$
|
(68)
|
Income tax (expense)
benefit
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
10
|
Net earnings (loss)
- common shareholder
|
$
|
(14)
|
$
|
—
|
$
|
(6)
|
|
$
|
(3)
|
$
|
(66)
|
Premiums and deposits
Total premiums and deposits include premiums on risk-based
insurance and annuity products net of ceded reinsurance (as defined
under IFRS as net premium income), premium equivalents on
self-funded group insurance ASO contracts, deposits on individual
and group segregated fund products as well as deposits on
proprietary mutual funds and institutional accounts. This measure
provides an indicator of top-line growth.
Premiums and
deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended
|
|
|
For the twelve
months ended
|
|
|
|
Dec.
31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
|
Dec.
31
2022
|
|
Dec. 31
2021
|
|
Total net
premiums
|
$
|
8,544
|
$
|
13,921
|
$
|
12,989
|
|
$
|
52,821
|
$
|
52,813
|
|
Policyholder deposits
(segregated funds)1
|
|
13,775
|
|
11,723
|
|
8,337
|
|
|
40,618
|
|
29,657
|
|
Self-funded premium
equivalents (ASO contracts)
and other
|
|
2,684
|
|
2,637
|
|
4,556
|
|
|
10,953
|
|
11,108
|
|
Proprietary mutual
funds and institutional deposits
|
|
19,162
|
|
15,984
|
|
21,772
|
|
|
69,787
|
|
75,225
|
|
Total premiums and
deposits
|
$
|
44,165
|
$
|
44,265
|
$
|
47,654
|
|
$
|
174,179
|
$
|
168,803
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 For
additional details, refer to note 14(b) to the Company's
December 31, 2022 annual consolidated financial
statements.
|
Assets under management (AUM) and assets under administration
(AUA)
Assets under management and assets under administration are
non-GAAP measures that provide an indicator of the size and volume
of the Company's overall business. Administrative services are an
important aspect of the overall business of the Company and should
be considered when comparing volumes, size and trends.
Total assets under administration includes total assets per
financial statements, proprietary mutual funds and institutional
assets and other assets under administration. Please refer to
the "Glossary" section of the Company's 2022 Annual Management's
Discussion and Analysis for additional information regarding
proprietary mutual funds and institutional net assets and other
assets under administration.
Total
AUA
|
|
|
|
|
|
|
|
|
|
Dec. 31
2022
|
|
Sept. 30
2022
|
|
Dec. 31
2021
|
|
Total assets per
financial statements
|
$
|
701,455
|
$
|
672,764
|
$
|
630,488
|
|
Other AUM
|
|
331,734
|
|
319,141
|
|
377,155
|
|
Total
AUM
|
$
|
1,033,189
|
$
|
991,905
|
$
|
1,007,643
|
|
Other
AUA1
|
|
1,464,523
|
|
1,392,368
|
|
1,283,949
|
|
Total
AUA1
|
$
|
2,497,712
|
$
|
2,384,273
|
$
|
2,291,592
|
|
|
|
|
|
|
|
|
|
1 2021
comparative figures have been restated to include Financial
Horizons Group and Excel Private Wealth Inc. assets under
administration in the Canada segment.
|
NON-GAAP RATIOS
A non-GAAP ratio is a financial measure in the form of a ratio,
fraction, percentage or similar representation that is not
disclosed in the financial statements of the Company and has a
non-GAAP financial measure as one or more of its components. These
financial measures do not have a standardized definition under IFRS
and might not be comparable to similar financial measures disclosed
by other issuers.
The non-GAAP ratios disclosed by the Company each use base
earnings (loss) as the non-GAAP component. Base earnings (loss)
reflect management's view of the underlying business performance of
the Company and provides an alternate measure to understand the
underlying business performance compared to IFRS net earnings.
- Base earnings per share - Base earnings (loss) for the
period is divided by the number of average common shares
outstanding for the period.
- Base return on equity - Base earnings (loss) for the
trailing four quarters are divided by the average common
shareholders' equity over the trailing four quarters. This measure
provides an indicator of business unit profitability.
For more information:
Media Relations
Contact:
|
Investor Relations
Contact:
|
Liz Kulyk
|
Deirdre
Neary
|
204-926-5012
|
647-328-2134
|
media.relations@canadalife.com
|
deirdre.neary@canadalife.com
|
SOURCE Great-West Lifeco Inc.